186 results about "Mouse Intestine" patented technology

The invention provides lactobacillus reuteri HNU872 and application of the lactobacillus reuteri HNU872 in preparation of intestinal inflammation related products. The invention discloses how the Lactobacillus reuteri HNU872 effectively alleviates the phenotype of DSS-induced mouse enteritis. The invention also discloses a preparation method of the Lactobacillus reuteri HNU872. Research results show that the Lactobacillus reuteri HNU872 can significantly relieve weight loss caused by enteritis, improve colon length, significantly improve the level of anti-inflammatory cytokines in serum and reduce the concentration of pro-inflammatory cytokines. In addition, the expression of the intestinal tight junction protein ZO-1 is obviously promoted. The lactobacillus reuteri HNU872 can regulate diversity and structure of intestinal microbiota of mice, inhibit enrichment of pathogenic bacteria and relieve inflammatory response. According to the invention, the action mechanism of the lactobacillus reuteri HNU872 in improving enteritis is clarified, and a solid scientific basis is provided for developing a microbial product based on probiotics as an alternative treatment strategy for ulcerative colitis.

The invention relates to application of 12-ketolithocholic acid in preparation of a medicine for preventing or treating acute ischemic intestinal injury. According to the application, 12-ketolithocholic acid (12-KLCA) is used for preventing or treating acute ischemic intestinal injury and is verified on a constructed classical intestinal ischemia reperfusion model, and a verification result shows that the 12-KLCA obviously improves intestinal histopathologic injury induced by intestinal ischemia reperfusion of a mouse, improves the survival rate of the mouse, and has a good application prospect in prevention or treatment of acute ischemic intestinal injury. The protein expression level of the apoptosis factor activated caspase-3 is reduced, the effect is obvious, safety and non-toxicity are achieved, and the side effect is small.

The invention relates to the field of microorganism sampling detection, in particular to escherichia coli sampling detection equipment for mouse experiments. The technical problem to be solved is that when mouse intestinal escherichia coli is sampled and detected, attention needs to be highly concentrated during manual operation, physical and mental exhaustion is easily caused, and the intestinal tract is damaged by slight carelessness. In addition, in the prior art, adipose tissue existing on the outer surface of the intestinal tract cannot be removed, and therefore the sampling detection result is affected. According to the technical scheme, the escherichia coli sampling and detecting equipment for the mouse experiment comprises a sampling box, a fixing assembly and the like; and a fixing assembly is mounted in the sampling box. According to the device, the left end and the right end of the intestinal tract of a mouse are fixed through the first clamping block and the second clamping block respectively, sterile water is injected into the intestinal tract of the mouse through an injection pipe for flushing, and cleaning of the intestinal tract of the mouse is completed, so that the pressure of manual operation is relieved, and meanwhile accidental damage to the intestinal tract of the mouse caused by manual operation is reduced.

The invention relates to Ackermann muciniphile as well as a regulator and application thereof, and relates to the technical field of biochemistry. The invention provides application of ackermann muciniphile in preparation of drugs for treating anxiety, and the ackermann muciniphile can significantly improve exploration interest, significantly reduce anxiety level and reverse anxiety manifestation caused by chronic stress, which indicates that the ackermann muciniphile has an effect of treating anxiety. The invention also provides an application of the regulator in preparation of medicines or health-care foods for regulating intestinal flora. The regulator comprises cape jasmine and fermented soybean soup. The regulator can obviously increase the quantity of Ackerman muciniphile in the intestinal tract of a mouse, so that the intestinal health is improved, and the micro-ecological balance of the intestinal tract of a human body is regulated.

The invention discloses a preparation method of cordyceps sobolifera polysaccharide and application of the cordyceps sobolifera polysaccharide in relieving acute chemical liver injury. Monosaccharide of the cordyceps sobolifera polysaccharide (abbreviated as CCPW) is composed of glucose, mannose and galactose according to the molar ratio of 8.918: 1: 0.356, and the relative molecular mass is 2.62 * 10 < 4 > Da. Efficacy experiments show that the cordyceps sobolifera homogeneous polysaccharide CCPW can significantly inhibit increase of ALT and AST in a CCl4-induced acute chemical liver injury model mouse, effectively improve the degree of liver cell disruption and swelling, relieve liver inflammatory response, relieve CCl4-induced mouse liver tissue injury, protect mouse intestinal barriers, recover intestinal microbial balance and have obvious liver protection activity. The cordyceps sobolifera polysaccharide CCPW is clear in composition and remarkable in effect, and has wide development and application prospects in the aspect of relieving acute chemical liver injury.

The invention discloses application of phlebopus portentosus polysaccharide in preparation of medicines or foods for regulating intestinal flora, reducing blood fat and reducing weight, and belongs to the technical field of biological medicines. The research on the effect of the phlebopus portentosus polysaccharide on obese model mice finds that the polysaccharide can reduce the occurrence of cardiovascular diseases such as atherosclerosis and the like, and has the effect of protecting the liver from being damaged. In addition, the liver injury state of the obese mouse is obviously relieved, the content of total short-chain fatty acid (SCFAs) of the obese mouse is increased, the species diversity of intestinal flora of the mouse is adjusted to a certain extent, and the colony composition is optimized.

The invention discloses a research method for researching an influence mechanism of high-fat diet on old-age health by using a mouse model, which comprises the following steps: S1, constructing a high-fat diet-induced mouse model: from normal diet feeding of mice to an old mouse stage, dividing the mice into two groups, and respectively performing high-fat diet feeding and normal diet feeding; s2, detecting physiological and functional indexes of the mice in the high-fat diet feeding group and the normal diet feeding group; s3, microbial diversity analysis: performing 16S rRNA sequencing to analyze the community structure of the intestinal microbiota of the mouse; s4, carrying out non-targeted metabonomics analysis: S4.1, carrying out intestinal tract non-targeted metabonomics sequencing; s4.2, carrying out non-targeted metabonomics sequencing on the liver tissues; s5, carrying out transcriptomics analysis; s6, performing conjoint analysis: performing the conjoint analysis on every two results of transcriptomics analysis, non-targeted metabonomics analysis and microbial diversity analysis; and S7, evaluating the influence of the high-fat diet on the health of the old rats by using the data obtained through analysis.

The invention provides bacillus licheniformis F0726 for improving neuroinflammation of Alzheimer's disease and application of the bacillus licheniformis F0726. Relates to the microbial field. Experiments prove that the bacillus licheniformis F0726 can improve spatial learning and memory impairment of AD model mice and reduce TNF-alpha and IL-1beta in serum of the AD mice in Alzheimer's disease model mice induced by injecting A beta oligomer into the brain; according to the invention, the content of IL-10 is increased, the alteration of AD mouse intestinal flora is improved, and a new way and potential probiotic resources are provided for developing medicines related to prevention and treatment of Alzheimer's disease.

The invention discloses a construction method and application of a GSDMB intestinal epithelium specific knock-in mouse model. The construction method comprises the following steps: (1) designing gRNA according to an ROSA26 gene, constructing a Donor vector containing a GSDMB gene, introducing the gRNA and the Donor vector and Cas mRNA into a fertilized egg of a receptor mouse, transplanting the fertilized egg and Cas mRNA into a pseudopregnant mouse body for reproduction, and screening out a GSDMB gene knock-in F0-generation mouse; (2) mating and breeding the F0 generation mouse and a wild type mouse, and screening out an F1 heterozygote mouse with GSDMB knocked in; (3) carrying out inbreeding propagation on the F1 heterozygote mouse, and screening out an F2 homozygote mouse in which GSDMB is knocked; (4) the F2 homozygote mouse and the intestinal epithelium specific Vilin-Cre transgenic mouse are subjected to mating breeding, and a heterozygote mouse with GSDMB intestinal epithelium specific knock-in is screened out; and (5) carrying out inbreeding propagation on the heterozygote mouse with the GSDMB intestinal epithelium specific knock-in, and screening out the homozygote mouse with the GSDMB intestinal epithelium specific knock-in.

The invention belongs to the technical field of biology, and particularly relates to a construction method and application of a model with fusobacterium nucleatum damaged mouse intestinal tract organoid, and the construction method comprises the following steps: separating mouse intestinal tract organoid; obtaining a culture supernatant with fusobacterium nucleatum; obtaining a cell-free extract with fusobacterium nucleatum; viable bacteria with fusobacterium nucleatum are obtained; and treating the mouse intestinal organ with the fusobacterium nucleatum culture supernatant or the fusobacterium nucleatum cell-free extract or the fusobacterium nucleatum viable bacteria to obtain the model of the mouse intestinal organ damaged by the fusobacterium nucleatum. The construction method of the organ-like model with the fusobacterium nucleatum damaged intestinal tract is simple, operability and convenience can be increased for further research on a regulation mechanism of the fusobacterium nucleatum damaged intestinal tract, and a reliable and accurate research tool is provided for gastrointestinal diseases such as inflammatory bowel diseases and colorectal cancer.

The invention provides an application of intestinal tract Ticam1 in regulation and control of MASH intestinal tract inflammatory response, the application is characterized in that the Ticam1 in the intestinal tract is inhibited, the growth of Ackermania mucilaginosa is promoted, and the strain code QAA37749.1 is used for catalyzing the conversion of betaine and improving MASH. The invention also provides an application of the intestinal tract Ticam1 in preparation of an MASH drug and a corresponding MASH treatment drug. Research finds that Ticam1 can aggravate intestinal injury of HFD mice, and deletion of Ticam1 in IEC can relieve HFD-induced hepatitis and hepatic fibrosis, improve HFD-induced metabolic disorder and cause change of intestinal microbiome, and further experiment and analysis are combined to obtain an influence mechanism of Ticam1 on MASH, so that a new thought and approach are provided for preparation of MASH treatment drugs, and the application has a broad application prospect. And the method has a remarkable application prospect.

The invention belongs to the technical field of biological medicines, and discloses application of chrysin in preparation of a medicine for treating alcoholic liver diseases. Wherein chrysin is used for treating the alcoholic liver disease by improving intestinal flora disorder of ALD mice. The research proves that chrysin has a relatively good protective effect on ALD mice from analysis of mouse liver function indexes, blood fat indexes, and richness and diversity of intestinal flora.

The invention discloses a construction method and application of a probiotic engineering bacterium EcNpAm targeting animal intestinal tracts and improving inflammation. According to the present invention, the heterologous expression of the immunomodulatory protein Amuc1100 is successfully achieved through the gene engineering technology by using the Escherichia coli Niss1917 (EcN) as the host and using the anaerobic inducible plasmid pnirBMisL as the expression vector, and the novel engineering bacterium EcNpAm suitable for the animal intestinal anaerobic environment is constructed; furthermore, the expression efficiency of the target protein is represented by fusion expression of green fluorescent protein (GFP). The engineering bacterium is applied to prevention and treatment of animal intestinal inflammation, and successfully realizes targeted delivery of therapeutic protein to intestinal tracts of mice. Experiments show that EcNpAm can effectively relieve typical symptoms such as weight loss, colon shortening, pathological injury, colitis and the like of mice induced by dextran sodium sulfate (DSS) and protect integrity and functions of an intestinal barrier structure.

The invention discloses Kluyveromyces marxianus KUST3801 and application thereof in relieving constipation, and the preservation number of the Kluyveromyces marxianus KUST3801 is CGMCC (China General Microbiological Culture Collection Center) NO.32767. The Kluyveromyces marxianus strain is classified and named as Kluyveromyces marxianus, and the Kluyveromyces marxianus strain is named as Kluyveromyces marxianus. The sequence of the 16SrRNA is as shown in SEQ ID NO. 1; the composition is used for improving constipation symptoms. After the kluyveromyces marxianus KUST3801 is applied, the excrement water content and the small intestine propulsion rate of a mouse with ICR constipation induced by loperamide hydrochloride are remarkably improved, and the defecation frequency and the defecation number within the same time are remarkably increased; intestinal mucosa tissues of constipation mice can be protected, and intestinal mucosa injury is relieved; the concentration of SP and MTL is obviously improved, and the concentration of VIP is reduced; iL-6 concentration is reversed, and inflammatory response is relieved; the concentrations of acetic acid, butyric acid, isobutyric acid and isovaleric acid in the short-chain fatty acid are obviously higher than those of mice with constipation, and the composition has a relatively strong effect of relieving constipation symptoms.

The invention relates to the technical field of biology, in particular to a composition, a culture medium and application of the culture medium in intestinal organ culture. The glucosamine hydrochloride is applied to culture of intestinal organs for the first time, organ proliferation and differentiation can be effectively promoted, and the number of formed organs is remarkably increased. On the basis, a three-dimensional culture system for staged time sequence induction in a postpartum newborn period, a child period and an adult period is constructed, and accurate construction of intestinal organs of the mice in different development periods is realized by combining dynamic regulation and control of an extracellular matrix and combinatorial optimization of growth factors; and an in-vitro model covering multiple time sequence stages is provided for intestinal development mechanism research and disease modeling.

The utility model discloses a mouse intestinal tract longitudinal cutting table which comprises a base and a cover, and the cover covers the base. The two ends of the base are each provided with a protruding stick frame, and a plurality of grooves are formed in each stick frame at equal intervals and correspond to the grooves in the table top of the base in a one-to-one mode. The cover is provided with a plurality of through grooves, and the part, between every two adjacent through grooves, of the cover forms a cutting guide edge. The mouse intestinal tract longitudinal cutting table is used for longitudinally cutting the intestinal tract tissue of a mouse, the operation is simple and rapid, the intestinal tract tissue longitudinal cutting effect is good, and the time from in-vitro to fixation of the intestinal tissue can be effectively shortened.

The invention discloses a composition for synergistically regulating intestinal flora and application thereof. The composition comprises the following components in parts by weight: 10-80 parts of a cordyceps militaris extract, 2-40 parts of quercetin, 5-50 parts of prebiotics and 5-80 parts of nucleotide. The compositions provided by the invention supplement each other, have a synergistic effect, are compounded according to a scientific proportion, can improve the diversity of intestinal microorganisms of mice and the abundance of species, and can significantly improve intestinal inflammation symptoms in a mouse colitis model.

The mouse intestinal tumor cell injector comprises a handle, an injection device installed in the handle, and a radially telescopic support ring structure connected with the handle, tumor cells can be discharged from a first injection needle by operating a first push rod, and antibiotics can be discharged from a second injection needle by operating a second push rod; when the support ring structure is in a contracted state, the first injection needle and the second injection needle are located in the support ring structure; when the support ring structure is in an expanded support state, the needle heads of the first injection needle and the second injection needle can both extend to the outside of the outer edge of the support ring structure and are inserted into the mouse intestinal wall. The present application supports the mouse intestine by the support ring structure, supports the insertion of the first injection needle and the second injection needle into the mouse intestinal wall, ensures that only the mouse intestinal endothelium is punctured and the mouse intestinal canal is not punctured, ensures that tumor cells are injected into the mouse intestinal wall, and when the tumor cells are injected, antibiotics are also injected for anti-inflammatory treatment, which is beneficial to the recovery of the mouse intestinal puncture point.

The invention discloses a saccharomyces boulardii colon delivery system which comprises the following steps: the survival rate in gastric juice is enhanced, and the residence time in the colon is increased, so that the treatment effect of the saccharomyces boulardii is enhanced. Saccharomyces boulardii is taken as a research object, in order to improve the bioavailability of the Saccharomyces boulardii in gastrointestinal tracts and prolong the adhesion time of bacteria in intestinal tracts, a layer-by-layer electrostatic self-assembly method is adopted, PDAD (poly dimethyl diallyl ammonium chloride), PSS (sodium polystyrene sulfonate), CS (chitosan) and SA (sodium alginate) are taken as biological membranes to coat the Saccharomyces boulardii, and the coated Saccharomyces boulardii is prepared. Then a series of characterization is carried out, and the effect of the delivery system is verified through in-vitro artificial gastric juice tolerance tests and mouse intestinal colonization.

The invention belongs to the technical field of biology, and discloses a preparation method of an intestinal plexus patch, which comprises the following steps: killing an intestinal tract donor, fixing intestinal tissue segments of duodenum, jejunum, ileum or colon by using paraformaldehyde, and dehydrating to obtain dehydrated intestinal tissue segments; washing the dehydrated intestinal tissue section and removing mesentery, fat and Pari's lymph nodes attached to the jejunum, cutting an intestinal mass of about 4-6mm perpendicular to the intestinal tissue section, flatly laying the intestinal mass on a glass slide, dropwise adding a PBS (Phosphate Buffer Solution) of Triton X-100, fixing the intestinal mass by using a smooth surface of a pair of tweezers, stripping muscle tissues along the annular muscle direction, and drying the intestinal mass in a drying oven. The intestinal slices with intermuscular nerve plexus are obtained; finally, the intestinal piece with the intermuscular nerve plexus is cleaned, then fluorescent staining and piece sealing are conducted, and the mouse intestinal nerve plexus patch is obtained. The preparation method of the mouse intestinal nerve plexus patch has the advantages of being convenient, rapid and the like.

Disclosed herein is a custom platform called NSC-seq that can be used for cell lineage and cell division tracking in a temporal fashion but also with single-cell resolution. With simultaneous integration of single-cell transcriptomics with lineage barcoding and temporal recording information, NSC-seq facilitates the generation of multidimensional datasets for elucidating functional heterogeneity and clonal events in vivo. We apply this platform (i) to decipher lineage branching of mouse embryonic development, (ii) to record clonal dynamics of the adult intestinal epithelium, and (iii) to track clonal composition of the mouse intestinal tumors. In addition, we apply NSC-seq to assess a comprehensive gene expression phenotype for individual gene knockout at the single-cell level using existing whole-genome CRISPR knockout screening plasmid libraries. Overall, NSC-seq enables in vivo temporal recording of mammalian development and cancer at single-cell resolution.

The invention provides application of a compound azelaic acid in preparation of a medicine for preventing and treating sepsis acute lung injury. Animal experiments show that azelaic acid is highly enriched in intestinal tracts and lungs of mice with ketogenic diet and is closely related to the occurrence and development process of sepsis acute lung injury. The compound azelaic acid can obviously inhibit lung inflammatory cell infiltration, inflammatory factor generation and lung cell apoptosis on the animal level, and can be used for preparing the medicine for preventing and treating acute lung injury caused by sepsis.

The application discloses application of Clostridium herbivorans in improving litter performance of mammals, and a probiotic preparation containing Clostridium herbivorans, wherein the viable bacterial count of Clostridium herbivorans in the probiotic preparation is 10 6 ~10 10 million / mL. After the Clostridium herbivorans colonizes in the intestinal tract of mice, the number of litters and the number of live litters of the mice can be improved.

To provide a culture medium for inducing directional differentiation of mouse intestinal organoids into intestinal endocrine cells and applications therefor.SOLUTION: A Mek inhibitor PD0325901, a Wnt inhibitor IWP-2 and a Notch inhibitor DAPT are added into a mouse small intestine organoid standard condition (ENR) culture medium, to induce mouse small intestine organoids to be differentiated into mature intestinal endocrine cells, thereby achieving the construction of the mouse intestinal endocrine cell induction model. The induction culture medium is used to induce mouse intestinal organoids to be differentiated into intestinal endocrine cells. The culture medium is replaced every two days following the initiation of differentiation of mouse small intestine organoids. Following 4 days of differentiation, the culture solution is removed by aspiration. A PBS buffer is added and sprayed, followed by centrifugation and removal of a supernatant. Resuspension is conducted in 4°C Advanced DMEM, followed by centrifugation and removal of the supernatant, and then resuspension in Advanced DMEM and Matrigel.SELECTED DRAWING: Figure 4

The invention relates to the technical field of biology, in particular to a probiotic composition for reducing blood sugar and application thereof.The probiotic composition comprises bifidobacterium longum subsp. Longum FMBL B241770LS and bifidobacterium animalis subsp. Lactis FMBL B24304AHDM which are preserved in the China Center for Type Culture Collection on September 21, 2024 with the preservation number of CCTCC NO: M 20241993 and preserved in the China Center for Type Culture Collection on November 18, 2024 with the preservation number of CCTCC NO: M 20241993 with the preservation number of CCTCC NO: M 20241993 with the preservation number of CCTCC NO: M 20241993 with the preservation number of CCTCC NO: M 20241993 with the the preservation number is CTCC (China Type Culture Collection) NO: M 20242505; the compound has a good inhibition effect on pathogenic bacteria, can obviously reduce oral glucose tolerance and insulin tolerance of T2DM mice, reduce abnormal fluctuation of postprandial blood glucose, reduce fasting blood glucose, fasting insulin level and blood fat level, relieve insulin resistance, effectively regulate intestinal flora imbalance and promote generation of short-chain fatty acid in intestinal tracts of the T2DM mice.

The invention discloses an application of mecobalamin in preparation of a preparation for improving intestinal flora imbalance of a subject or treating and / or preventing related diseases of intestinal flora imbalance of the subject, mecobalamin can regulate intestinal flora in the aspects of Alpha diversity, Beta diversity, gate-level mouse intestinal flora structure, family-level mouse intestinal flora structure and the like, and can be used for treating and / or preventing intestinal flora imbalance of the subject. The pharmaceutical composition has a preparation developed to improve intestinal flora imbalance of a subject, or treat and / or prevent diseases related to the intestinal flora imbalance of the subject.

The invention relates to the technical field of biological medicines, in particular to application of extracellular vesicles of Ackermann muciniphila in preparation of trichina control products. Experiments prove that by supplementing the AKK bacterium extracellular vesicles, the intestinal flora of a mouse can be remarkably improved, the immune balance of a host is regulated, and the pathological change of the intestinal tract of the mouse can be improved. Experimental results show that the AKK bacterium extracellular vesicles have a certain protection effect on trichina infected mice and have the advantages of being efficient, safe, easy to produce on a large scale and the like, and a brand new technical solution is provided for prevention and treatment of trichinosis.

A mouse intestinal pathological section embedding box is provided with an anti-collision block for fixing a Swiss roll, two non-woven fabric sheets, and a punching assembly for punching the Swiss roll. When in operation, the Swiss roll is fixed by the anti-collision block and the two non-woven fabric sheets, so that gaps are not easily generated in the formed wax block, and the subsequent sectioning and staining are more favorable, and the intestinal canal is not damaged. The method for making pathological sections comprises the following steps: separating the matched tool box from the embedding box body, punching the anti-collision block with a suitable punch, cleaning and rolling the mouse intestinal canal fixed by formalin into a Swiss roll; inserting the Swiss roll into the hole by using external force and flattening the protruding part of the intestinal canal tissue with a blade, placing the two layers of non-woven fabric to clamp the anti-collision block into the embedding box for tissue dehydration, peeling off the Swiss roll from the anti-collision block after dehydration and making a wax block; freezing and re-solidifying after heating and melting the paraffin, and then sectioning. The method can improve the overall morphological quality of pathological sections, and there is no phenomenon of structural loss.

The invention belongs to the technical field of intestinal flora sampling, and particularly relates to an experimental mouse intestinal flora sampling device which comprises a mounting cylinder, the side wall of the mounting cylinder is fixedly connected with a controller and a buzzer, the right side of the mounting cylinder is of an open structure, and the inner wall of the left side of the mounting cylinder is connected with an annular plate through a spring. And an injector is inserted into the right side of the mounting cylinder, a mounting frame is fixedly connected to the front side wall of the mounting cylinder, and the mounting frame is of a U-shaped structure. When the insertion head of the sampling device is inserted from the anus of the mouse, the diameter of the insertion head is reduced, so that the problems that the insertion head is too thick, the mouse is severely painful, the stress hormone level of the mouse is promoted to rise, and the intestinal flora composition is interfered are solved; and the insertion head can be expanded to a proper diameter, so that the problem that the insertion head is blocked by dietary fibers in intestinal tracts of mice is avoided.

The present invention provides a preparation method for extracting volatile oil of Chimonanthus chinensis leaves by ultrasonic-assisted steam distillation and its application in improving ulcerative colitis drugs. The method includes crushing Chimonanthus chinensis leaves to a specific particle size and then performing ultrasonic treatment and steam distillation under optimized conditions, and finally achieving 2.5% to 4% high-efficiency extraction. Volatile oil is rich in phellandrene, α-terpineol and (+)-limonene, accounting for more than 50% of the total mass. Pharmacological experiments show that this volatile oil can significantly reduce the levels of pro-inflammatory factors interleukin 6 (IL-6), interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α) in mouse serum, increase anti-inflammatory factor interleukin 10 (IL-10); increase the expression of tight junction protein ZO-1, protect the integrity of mouse intestinal epithelial barrier; and significantly downregulate the expression of proline hydroxylase 3 factor of HIF-1 pathway to inhibit inflammation.